| __timestamp | Regeneron Pharmaceuticals, Inc. | Takeda Pharmaceutical Company Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 2614539000 | 1256834000000 |
| Thursday, January 1, 2015 | 3711019000 | 1271973000000 |
| Friday, January 1, 2016 | 4560733000 | 1173296000000 |
| Sunday, January 1, 2017 | 5475166000 | 1274610000000 |
| Monday, January 1, 2018 | 6276700000 | 1437534000000 |
| Tuesday, January 1, 2019 | 7081200000 | 2201424000000 |
| Wednesday, January 1, 2020 | 7377200000 | 2203504000000 |
| Friday, January 1, 2021 | 13634200000 | 2462160000000 |
| Saturday, January 1, 2022 | 10612500000 | 2783406000000 |
| Sunday, January 1, 2023 | 11301400000 | 2832257000000 |
| Monday, January 1, 2024 | 12231500000 | 2832257000000 |
Igniting the spark of knowledge
In the ever-evolving landscape of pharmaceuticals, the financial performance of companies like Regeneron Pharmaceuticals, Inc. and Takeda Pharmaceutical Company Limited offers a window into industry trends. Over the past decade, Regeneron has seen its gross profit grow by approximately 332%, from $2.6 billion in 2014 to $11.3 billion in 2023. This remarkable growth underscores Regeneron's innovative prowess and strategic market positioning.
Meanwhile, Takeda, a stalwart in the industry, has maintained a steady trajectory with its gross profit hovering around the $2.8 trillion mark in recent years. Despite the absence of data for 2024, Takeda's consistent performance highlights its robust global operations and diversified portfolio.
These insights not only reflect the companies' financial health but also their ability to adapt and thrive in a competitive market, making them key players to watch in the pharmaceutical sector.
Gross Profit Analysis: Comparing Novo Nordisk A/S and Regeneron Pharmaceuticals, Inc.
Bristol-Myers Squibb Company and Regeneron Pharmaceuticals, Inc.: A Detailed Gross Profit Analysis
Bristol-Myers Squibb Company and Takeda Pharmaceutical Company Limited: A Detailed Gross Profit Analysis
Comparing Innovation Spending: Regeneron Pharmaceuticals, Inc. and Takeda Pharmaceutical Company Limited
Gross Profit Trends Compared: Regeneron Pharmaceuticals, Inc. vs Taro Pharmaceutical Industries Ltd.
Gross Profit Trends Compared: Takeda Pharmaceutical Company Limited vs Walgreens Boots Alliance, Inc.
Takeda Pharmaceutical Company Limited vs Grifols, S.A.: A Gross Profit Performance Breakdown
Who Generates Higher Gross Profit? Takeda Pharmaceutical Company Limited or Arrowhead Pharmaceuticals, Inc.
Takeda Pharmaceutical Company Limited vs Vericel Corporation: A Gross Profit Performance Breakdown
Takeda Pharmaceutical Company Limited vs Supernus Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Gross Profit Comparison: Takeda Pharmaceutical Company Limited and Amphastar Pharmaceuticals, Inc. Trends